Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.
Sign up for the Good Day BIO Newsletter >
June 16-19, 2025 | Boston, MA
October 23-24, 2024Washington, DC
November 18-20, 2024Washington, DC
Fall 2025San Francisco, CA
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.
David (Dave) Lawrence Chief Business Officer Neurotrauma Sciences, LLC. Alpharetta, GA
Mike Knievel Sr. Director, Procurement Gilead Sciences Foster City, CA
Robert Freeberg Senior Director, Procurement Sangamo Therapeutics, Inc. Richmond, CA
Michelle Charpentier Head of Tech Ops Global Procurement BioMarin Pharmaceutical Inc. Novato, CA
Lynn M. Cilinski Vice President, Controller & Treasurer MacroGenics, Inc. Rockville, MD
Nicol Godfrey Director, Procurement Operations Exelixis Alameda, CA
Pat Magnafichi
Alameda, CA
Ryan Stoeckel Associate Director, Procurement Verve Therapeutics Cambridge, MA